Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

AstraZeneca (AZN) is identified as a strong momentum stock by Zacks, despite its current #3 (Hold) Zacks Rank, due to its robust 'A' VGM Score and 'B' Momentum Style Score. The biopharmaceutical company's shares have gained 5.2% over the past four weeks, supported by four analysts revising their fiscal year 2025 earnings estimates upwards in the last 60 days, pushing the Zacks Consensus Estimate to $4.54 per share. This positive earnings revision trend, coupled with an average earnings surprise of +3.5%, suggests AZN warrants consideration for investors' shortlists.

Analysis

AstraZeneca (AZN) presents a nuanced investment profile, currently holding a neutral Zacks Rank #3 (Hold) while simultaneously displaying strong underlying positive indicators. The stock has earned a top-tier 'A' for its overall VGM Score and a favorable 'B' for its Momentum Style Score, which is corroborated by its recent share price performance, showing a 5.2% gain over the past four weeks. Critically, forward-looking sentiment from analysts is positive, with four analysts having revised their fiscal 2025 earnings estimates upward within the last 60 days. This has lifted the Zacks Consensus Estimate by $0.04 to $4.54 per share. This trend of positive earnings revisions is further supported by the company's historical ability to exceed expectations, reflected in an average earnings surprise of +3.5%. The combination of these factors suggests that while the primary rank is neutral, momentum and earnings revision trends are signaling potential upside not yet fully captured by the Hold rating.

Key Decisions for Investors

• Investors should note the divergence between the neutral Zacks #3 (Hold) rank and the positive underlying signals, such as the 'A' VGM score and recent upward earnings revisions for fiscal 2025.
• Given the 'B' Momentum Style Score and 5.2% share price increase over the last month, momentum-oriented investors could view the stock as a candidate for their watchlist, as the current trend appears positive.
• A key factor to monitor will be any potential upgrade in the Zacks Rank, as a move to #2 (Buy) or #1 (Strong Buy) would serve as strong confirmation of the bullish sentiment currently reflected in the analyst estimate revisions and style scores.